3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
13
Neoplasms
8
Breast Neoplasms
4
Hypogonadism
3
Testicular Neoplasms
2
Polycystic Ovary Syndrome
2
Fatigue
2
Dyspareunia
2
Arthralgia
2
Vaginitis
1
Sleep Apnea, Obstructive
1
Sleep Apnea Syndromes
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Osteoporosis
1
Obesity
1
Neoplasm Metastasis
1
Muscle Weakness
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Metabolic Syndrome
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Infertility
1
Hot Flashes
1
Eunuchism
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms, Male
1
Interventions
Cyclophosphamide
31
Trastuzumab
30
Paclitaxel
28
Docetaxel
22
Taxes
18
Doxorubicin
18
Lapatinib
15
Radiotherapy
14
Capecitabine
14
Bevacizumab
13
Tamoxifen
12
Carboplatin
11
Filgrastim
9
sargramostim
8
Granulocyte-Macrophage Colony-Stimulating Factor
8
Chemotherapy, Adjuvant
8
exemestane
7
Vorinostat
7
Letrozole
7
Immunohistochemistry
7
Gemcitabine
7
Anastrozole
7
Albumin-Bound Paclitaxel
7
pegfilgrastim
6
Neoadjuvant Therapy
6
Magnetic Resonance Spectroscopy
6
Immunoenzyme Techniques
6
Goserelin
6
Flow Cytometry
6
Everolimus
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Breast Neoplasms, Male
×
Testosterone
×
Clear all
NCT05156606
2024-08-09
T&T
University Medical Center Groningen
Phase NA
Terminated
5 enrolled